C4 Therapeutics, Inc. - CCCC

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$232.4M
QoQ value delta ($000)
+$79.63M (+52.12%)
Implied price effect (QoQ)
+34.9%
Shares
Total shares
90,224,752
QoQ shares delta
+10,214,911 (+12.77%)
Total shares held by funds (by quarter)

Market chart (CCCC)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 123 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
MORGAN STANLEY 23,860 9,072,400 0.0%
RA CAPITAL MANAGEMENT, L.P. 21,040 8,000,000 0.22%
Bain Capital Life Sciences Investors, LLC 18,862 7,171,910 1.7%
Lynx1 Capital Management LP 18,407 6,998,902 2.91%
VANGUARD CAPITAL MANAGEMENT LLC 10,156 3,861,852 0.0%
Soleus Capital Management, L.P. 10,004 3,803,942 0.41%
VANGUARD GROUP INC 8,365 4,379,815 0.0%
TWO SIGMA INVESTMENTS, LP 7,983 3,035,634 0.01%
WASATCH ADVISORS LP 7,789 2,961,761 0.05%
JPMORGAN CHASE & CO 7,574 3,223,054 0.0%
CITADEL ADVISORS LLC 6,808 2,588,615 0.0%
RENAISSANCE TECHNOLOGIES LLC 6,474 2,461,815 0.01%
GOLDMAN SACHS GROUP INC 6,278 2,387,378 0.0%
BANK OF AMERICA CORP /DE/ 6,204 2,359,241 0.0%
Squadron Capital Management LLC 5,917 2,250,000 2.17%
BlackRock, Inc. 5,387 2,048,526 0.0%
SILVERARC CAPITAL MANAGEMENT, LLC 5,027 1,911,785 0.51%
ACADIAN ASSET MANAGEMENT LLC 4,968 1,890,914 0.01%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 3,667 1,394,440 0.0%
MILLENNIUM MANAGEMENT LLC 3,664 1,393,342 0.0%
JANE STREET GROUP, LLC 3,542 1,346,796 0.0%
D. E. Shaw & Co., Inc. 2,788 1,060,331 0.0%
GEODE CAPITAL MANAGEMENT, LLC 2,502 951,043 0.0%
WELLS FARGO & COMPANY/MN 2,282 867,911 0.0%
ORBIMED ADVISORS LLC 2,252 856,353 0.04%